Notably, elevated levels of CASP8, latency-associated peptide of transforming growth factor beta-1 (LAP TGF-β1), HGF, and ARG1 were observed among breast cancer patients diagnosed within 5 years of follow-up (Fig. S5). This evidence concerns the gene CASP8 and breast cancer.